["{\n\"step_by_step_thinking\": \"The provided documents discuss various aspects of pancreatic cancer, including its treatment, epidemiology, and biology. There is no mention of Axitinib or any clinical trials that involve this medication. Therefore, based on the available information, it can be concluded that Axitinib's effectiveness in prolonging survival of pancreatic cancer patients is not discussed or evaluated.\",\n\"answer_choice\": \"B\""]